Olanzapine versus placebo in acute mania treatment responses in subgroups

Journal of Clinical Psychopharmacology

Volumn 23, Issue 4, 2003, Pages 370-376

  Baldessarini, Ross J ^a,b,k   Hennen, John ^a,b   Wilson, Michael ^c   Calabrese, Joseph ^d   Chengappa, Roy ^e   Keck Jr , Paul E ^f   McElroy, Susan L ^f   Sachs, Gary ^b   Vieta, Eduard ^g   Welge, Jeffrey A ^f   Yatham, Lakshmi N ^h   Zarate Jr , Carlos A ⁱ   Baker, Robert W ^j   Tohen, Mauricio ^a,b,j  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BUTLER UNIVERSITY   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF BARCELONA   (Spain)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^j ELI LILLY AND COMPANY   (United States)

^k MCLEAN HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MULTICENTER STUDY; ONSET AGE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEX DIFFERENCE; SUBSTANCE ABUSE; TREATMENT OUTCOME;

EID: 0042133412     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000085410.08426.9a     Document Type: Article

References (23)

1. Baldessarini RJ, Tarazi FI. Drugs and the treatment of psychiatric disorders: antipsychotic and antimanic agents. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill Press; 2001:485-520.
2. Tohen M, Sanger TM, McElroy SL, et al, and the Olanzapine HGEH Study Group. Olanzapine vs. placebo in the treatment of acute mania. Am J Psychiatry. 1999;156:702-709.
3. Tohen M, Jacobs TG, Grundy SL, et al. Efficacy of olanzapine in acute bipolar mania. Arch Gen Psychiatry. 2000;57:841-849.
4. Goldberg JF, Garno JL, Leon AC, et al. A history of substance abuse complicates remission from acute mania in bipolar disorder. J Clin Psychiatry. 1999;60:733-740.
5. Brotman MA, Fergus EL, Post RM, et al. High exposure to neuroleptics in bipolar patients: a retrospective review. J Clin Psychiatry. 2000;6:68-72.
6. Carlson GA, Bromet EJ, Sievers S. Phenomenology and outcome of subjects with early- and adult-onset psychotic mania. Am J Psychiatry. 2000;157:213-219.
7. Montgomery SA, Schatzberg AF, et al. Pharmacotherapy of depression and mixed states in bipolar disorder. J Affect Disord. 2000;59(suppl 1): 39-56.
8. Bowden CL. Clinical correlates of therapeutic response in bipolar disorder. J Affect Disord. 2001;67:257-265.
9. Coryell W, Leon AC, Turvey C, et al. The significance of psychotic features in manic episodes: report from the NIMH collaborative study. J Affect Disord. 2001;67:79-88.
10. Kupka RW, Nolen WA, Altshuler LL, et al. Preliminary summary of demographics, course of illness and response to novel treatments. Br J Psychiatry. 2001;41(suppl):177-183.
11. Viguera AC, Baldessarini RJ, Tondo L. Response to lithium maintenance treatment in bipolar disorders: comparison of women and men. Bipolar Disord. 2001;3:245-252.
12. Gonzalez-Pinto A, Tohen M, Lalaguna B, et al. Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine. J Clin Psychopharmacol. 2002;22:450-454.
13. Maj M, Pirozzi R, Bartoli L, Magliano L. Long-term outcome of lithium prophylaxis in bipolar disorder with mood-incongruent psychotic features: a prospective study. J Affect Disord. 2002;71:195-198.
14. Baldessarini RJ, Tondo L, Hennen J. Latency and episodes before treatment: effects on pretreatment morbidity but not response to maintenance treatment in bipolar I and II disorders. Bipolar Disord. 2003;5:169-179.
15. Tohen M, Zarate CA Jr, Hennen J, et al. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry. 2003. In press.
16. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429-435.
17. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278-296.
18. Kay SR, Fiszbein A, Opler A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
19. Spearing MK, Post PM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impression scale for use in bipolar illness (CGI-BP). Psychiatry Res. 1997;73:159-171.
20. Diggle P, Liang K-Y, Zeger SL. Analysis of Longitudinal Data. New York, NY: Oxford University Press; 1995.
21. Allison PD. Event History Analysis: Regression for Longitudinal Event Data. Newbury Park, CA: Sage; 1984:14-22.
22. Baldessarini RJ. Treatment research in bipolar disorder: issues and recommendations. CNS Drugs. 2002;16:721-729.
23. Hennen J. Methods employed in experimental therapeutics research in bipolar disorder. Bipolar Disord. 2003;5:156-168.